Mergers & Acquisitions ·
On June 25, 2026, ENDRA Life Sciences Inc. entered into an Agreement and Plan of Merger with ASP Isotopes Inc. (ASPI)…
NDRAENDRA Life Sciences Inc.
On June 25, 2026, ENDRA Life Sciences Inc. entered into an Agreement and Plan of Merger with ASP Isotopes Inc. (ASPI), Noble Africa LLC, and Renergen Limited. Under the terms, Noble Africa LLC will merge into a subsidiary of ENDRA, with Noble surviving as a wholly-owned subsidiary. Concurrently, Noble will raise approximately $50 million through the sale of Class A and Class B units at $6.57 per unit. ASPI will contribute its equity interest in Renergen to Noble. ENDRA will be renamed Noble Africa Inc. and will implement a dual-class stock structure (Class A and Class B). The merger is subject to stockholder approval and other closing conditions, including ENDRA maintaining a minimum cash balance of $3.8 million. ENDRA operates in the life sciences industry and is transitioning into the energy sector focusing on helium and LNG resources.